SGHT · ISSUER CIK 1531177
Sight Sciences, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 6 Sight Sciences, Inc. insiders reported $0.00 of open-market purchases and $653K of sales on SEC Form 4.
↗6 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 5 of 5 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$653KInsider selling
−$653KNet open-market
Oct 5, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 202616:43 | Oct 2, 2026 | SGHT | EVP, Operations & R&D | S · Sell10b5-1 | $8.85 | −2,988 | 261,990 | -1% | −$26K | ||
| Oct 5, 202616:43 | Oct 2, 2026 | SGHT | Chief Operating Officer | S · Sell10b5-1 | $8.85 | −25,260 | 639,449 | -4% | −$224K | ||
| Oct 5, 202616:42 | Oct 2, 2026 | SGHT | Chief Financial Officer | S · Sell10b5-1 | $8.85 | −7,208 | 216,829 | -3% | −$64K | ||
| Oct 5, 202616:40 | Oct 1, 2026 | SGHT | Chief Technology Officer, Director | S · Sell10b5-1 | $9.05 | −7,797 | 1,975,075 | -0% | −$71K | ||
| Oct 5, 202616:40 | Oct 1, 2026 | SGHT | President and CEO, Director, 10% Owner | S · Sell10b5-1 | $9.05 | −29,653 | 6,092,819 | -0% | −$268K | ||
| Aug 18, 202618:08 | Aug 10, 2026 | SGHT | Chief Legal Officer | A · GrantLate 8d | — | +181,818 | 181,818 | New | — |